Almost three quarters of the NCDs occur in low and middle-income countries.
Almost three quarters of the NCDs occur in low and middle-income countries.

Drugmakers Shifting Focus to NCDs in Poor Nations

Drugmakers Shifting Focus to NCDs in Poor Nations

Two decades after they were spurred into action to tackle AIDS in Africa, global drugmakers said on Wednesday they would invest $50 million over three years to fight cancer and other non-communicable diseases in poor countries.
Twenty-two companies, including Pfizer, Merck, Novartis, Roche, Sanofi and GlaxoSmithKline, will contribute funds and expertise to the project, which is backed by the World Bank.
The so-called Access Accelerated initiative was announced at the World Economic Forum in Davos and aims to improve both treatment and prevention.
In the past, the focus of healthcare in poorer parts of the world has been on fighting infectious diseases, whether through vaccinations, drug programs or the roll-out of anti-malarial bednets.
Today, however, the healthcare burden is shifting as deaths from these conditions decline and people in increasingly urbanized populations succumb to diseases such as cancer, diabetes, and heart and lung disorders fueled by western lifestyles, Reuters reported.
Such non-communicable diseases (NCDs) are responsible for nearly 70% of all deaths worldwide and almost three quarters of them occur in low and middle-income countries, says the World Health Organization.
Severin Schwan, the chief executive of Roche, the world’s largest maker of cancer drugs, said his company and others were already implementing preferential pricing for the developing world but cost was only one obstacle.
Countries in Africa, Asia and Latin America also need improved healthcare systems if patients are to benefit from the latest developments in medicine. “It has a lot to do with hospital infrastructure. You can’t administer modern cancer medicines if you don’t have sophisticated lab facilities,” he said. “We’re going to institutionalize cooperation in this area.”
Cancer is the initial focus and drug companies will work with the Union for International Cancer Control to test out new diagnostics and treatments in several cities around the world on a pilot basis.


Short URL : https://goo.gl/QEOiIv
  1. https://goo.gl/sEuG6M
  • https://goo.gl/KaQqqC
  • https://goo.gl/bta5Zf
  • https://goo.gl/FPSTey
  • https://goo.gl/VmDDBp

You can also read ...

Iran Preparing UNESCO Dossier for Iranian Railroads-Photo Jean Marc Fryburg
Cultural heritage officials, in cooperation with the Islamic...
Four Hajj Pilgrims Die
Four Iranian hajj pilgrims (three men and one woman) have lost...
Math, Chemistry Olympiad Winners
Iran has topped the 18th math and 10th chemistry international...
Three Killed  in Bus Crash
Three people were killed and 35 were injured when a bus...
Obesity and related health risks are responsible for 17% of deaths among Iranians.
Obesity is prevalent in low-income households in Tehran, and...
Sistan-Baluchestan is looking to overhaul its image for domestic and foreign travelers.
Work has begun on developing four coastal tourism resorts in...
Restricting the availability of jobs to EU nationals and access to social security will deter many from making the journey.
European nationals will still be able to pass freely without...
Iran Reviewing Rural Tourism Potentials
Iranian authorities will review the tourism potentials of 1,...

Add new comment

Read our comment policy before posting your viewpoints

Enter the characters shown in the image.